Annual EBITDA
-$161.92 M
+$49.15 M+23.29%
December 31, 2023
Summary
- As of February 20, 2025, GOSS annual EBITDA is -$161.92 million, with the most recent change of +$49.15 million (+23.29%) on December 31, 2023.
- During the last 3 years, GOSS annual EBITDA has risen by +$64.50 million (+28.49%).
- GOSS annual EBITDA is now -194985.54% below its all-time high of -$83.00 thousand, reached on December 31, 2016.
Performance
GOSS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$28.10 M
-$85.68 M-148.81%
September 30, 2024
Summary
- As of February 20, 2025, GOSS quarterly EBITDA is -$28.10 million, with the most recent change of -$85.68 million (-148.81%) on September 30, 2024.
- Over the past year, GOSS quarterly EBITDA has increased by +$15.80 million (+35.99%).
- GOSS quarterly EBITDA is now -148.81% below its all-time high of $57.58 million, reached on June 30, 2024.
Performance
GOSS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$52.24 M
+$7.47 M+12.52%
September 30, 2024
Summary
- As of February 20, 2025, GOSS TTM EBITDA is -$52.24 million, with the most recent change of +$7.47 million (+12.52%) on September 30, 2024.
- Over the past year, GOSS TTM EBITDA has increased by +$109.68 million (+67.73%).
- GOSS TTM EBITDA is now -6179.33% below its all-time high of -$832.00 thousand, reached on December 31, 2017.
Performance
GOSS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GOSS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | +36.0% | +67.7% |
| 3 y3 years | +28.5% | +48.0% | +76.0% |
| 5 y5 years | -10.4% | +42.9% | +70.2% |
GOSS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.3% | -148.8% | +48.7% | at high | +75.3% |
| 5 y | 5-year | at high | +28.5% | -148.8% | +55.7% | at high | +76.9% |
| alltime | all time | <-9999.0% | +28.5% | -148.8% | +67.8% | -6179.3% | +76.9% |
Gossamer Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.10 M(-148.8%) | -$52.24 M(-12.5%) |
| Jun 2024 | - | $57.58 M(-252.3%) | -$59.72 M(-61.5%) |
| Mar 2024 | - | -$37.81 M(-13.9%) | -$155.21 M(-4.1%) |
| Dec 2023 | -$161.92 M(-23.3%) | -$43.90 M(+23.4%) | -$161.92 M(-4.3%) |
| Sep 2023 | - | -$35.58 M(-6.2%) | -$169.20 M(-10.2%) |
| Jun 2023 | - | -$37.92 M(-14.8%) | -$188.40 M(-6.9%) |
| Mar 2023 | - | -$44.52 M(-13.0%) | -$202.37 M(-4.1%) |
| Dec 2022 | -$211.07 M(+0.8%) | -$51.18 M(-6.6%) | -$211.07 M(+0.5%) |
| Sep 2022 | - | -$54.78 M(+5.6%) | -$209.95 M(+0.4%) |
| Jun 2022 | - | -$51.89 M(-2.5%) | -$209.22 M(-0.9%) |
| Mar 2022 | - | -$53.22 M(+6.3%) | -$211.03 M(+0.8%) |
| Dec 2021 | -$209.40 M | -$50.06 M(-7.4%) | -$209.40 M(-3.9%) |
| Sep 2021 | - | -$54.04 M(+0.6%) | -$217.97 M(+1.0%) |
| Jun 2021 | - | -$53.70 M(+4.1%) | -$215.85 M(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$51.59 M(-12.0%) | -$225.54 M(-0.4%) |
| Dec 2020 | -$226.43 M(+29.2%) | -$58.64 M(+12.9%) | -$226.43 M(+4.4%) |
| Sep 2020 | - | -$51.92 M(-18.1%) | -$216.95 M(+1.3%) |
| Jun 2020 | - | -$63.39 M(+20.8%) | -$214.23 M(+9.6%) |
| Mar 2020 | - | -$52.47 M(+6.7%) | -$195.47 M(+11.5%) |
| Dec 2019 | -$175.28 M(+19.5%) | -$49.17 M(-0.1%) | -$175.28 M(-17.9%) |
| Sep 2019 | - | -$49.20 M(+10.2%) | -$213.41 M(+3.7%) |
| Jun 2019 | - | -$44.63 M(+38.2%) | -$205.85 M(+18.5%) |
| Mar 2019 | - | -$32.28 M(-63.0%) | -$173.72 M(+3.7%) |
| Dec 2018 | -$146.66 M(>+9900.0%) | -$87.30 M(+109.7%) | -$167.47 M(+106.7%) |
| Sep 2018 | - | -$41.64 M(+233.0%) | -$81.00 M(+105.8%) |
| Jun 2018 | - | -$12.50 M(-52.0%) | -$39.37 M(+46.5%) |
| Mar 2018 | - | -$26.03 M(+3028.7%) | -$26.86 M(+3128.7%) |
| Dec 2017 | -$1.15 M(+1289.2%) | -$832.00 K | -$832.00 K |
| Dec 2016 | -$83.00 K | - | - |
FAQ
- What is Gossamer Bio annual EBITDA?
- What is the all time high annual EBITDA for Gossamer Bio?
- What is Gossamer Bio annual EBITDA year-on-year change?
- What is Gossamer Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Gossamer Bio?
- What is Gossamer Bio quarterly EBITDA year-on-year change?
- What is Gossamer Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Gossamer Bio?
- What is Gossamer Bio TTM EBITDA year-on-year change?
What is Gossamer Bio annual EBITDA?
The current annual EBITDA of GOSS is -$161.92 M
What is the all time high annual EBITDA for Gossamer Bio?
Gossamer Bio all-time high annual EBITDA is -$83.00 K
What is Gossamer Bio annual EBITDA year-on-year change?
Over the past year, GOSS annual EBITDA has changed by +$49.15 M (+23.29%)
What is Gossamer Bio quarterly EBITDA?
The current quarterly EBITDA of GOSS is -$28.10 M
What is the all time high quarterly EBITDA for Gossamer Bio?
Gossamer Bio all-time high quarterly EBITDA is $57.58 M
What is Gossamer Bio quarterly EBITDA year-on-year change?
Over the past year, GOSS quarterly EBITDA has changed by +$15.80 M (+35.99%)
What is Gossamer Bio TTM EBITDA?
The current TTM EBITDA of GOSS is -$52.24 M
What is the all time high TTM EBITDA for Gossamer Bio?
Gossamer Bio all-time high TTM EBITDA is -$832.00 K
What is Gossamer Bio TTM EBITDA year-on-year change?
Over the past year, GOSS TTM EBITDA has changed by +$109.68 M (+67.73%)